HFrEF Treatment

studied byStudied by 3 people
5.0(2)
Get a hint
Hint

What is the general approach for initiating drugs in HFrEF

1 / 93

encourage image

There's no tags or description

Looks like no one added any tags here yet for you.

94 Terms

1

What is the general approach for initiating drugs in HFrEF

Initiate as many mortality reducing drugs as the patient can tolerate and then titrate up to target doses

New cards
2

Which decreases mortality in HF patients the most: adding a new class of medication or increasing the dose of the medications they are on?

Adding a new class of medications

New cards
3

What gives the most mortality reduction in HF patients?

Target doses of all GDMTs!!

New cards
4

If a patient is newly diagnosed with HFrEF when should they achieve maximally tolerated or target doses of GDMT medications?

3 months

New cards
5

If a patient is discharged from the hospital for HFrEF when should they achieve maximally tolerated or target doses of GDMT medications?

6 weeks

New cards
6

Which medication classes should be given to a heart failure patient first?

ARNI (or ACEi/ARB), Beta-blocker, MRA, and SGLT inhibitors

New cards
7

When should a HFrEF patient be put on a diuretic (loop diuretic)?

if they are experiencing persistent volume overload (any signs of congestion/hypervolemia) even after taking max doses of GDMT meds

New cards
8

When should a HFrEF patient be put on hydralazine/isosorbide dinitrate?

If they are an African American that is persistently symptomatic and on other GDMT meds

New cards
9

When should a HFrEF patient be put on ivabradine?

Patients with a resting HR >= 70 bpm on maximally tolerated beta-blocker and in sinus rhythm (may or may not have symptoms)

New cards
10

When should a HFrEF patient be put on vericiguat?

patients on GDMT meds with worsening HF evidenced by HF hospitalization or requirement for IV diuretics

New cards
11

After starting Entresto what should be assessed in 1-2 weeks?

tolerability, BP, electrolytes, and renal function

New cards
12

When do you increase the dose of Entresto?

every 1-2 weeks increase the dose stepwise to a target of 97/103 mg twice a day

New cards
13

Which patients start on the lower dose of Entresto?

patients already on a daily equivalent of <= 10 mg enalapril or <= 160 mg valsartan, ACEi/ARB naive, eGFR < 30 mL/min/1.73m2, >= 75 years old

New cards
14

Which patients start on the higher dose of Entresto?

On equivalent of > 10 mg of enalapril or > 160 mg valsartan

New cards
15

When should a HF patient get an ACEi/ARB instead of an ARNI?

if the patient is not able to get/take Entresto for various reasons.

New cards
16

what should be assessed in 1-2 weeks after starting an ACEi/ARB

tolerability. BP, electrolytes, renal function

New cards
17

When do you increase the dose of an ACEi/ARB in patients with HFrEF

every 1-2 weeks and increase the dose stepwise to target doses

New cards
18

What are the starting dose options for sacubitril/valsartan

24/26 mg or 49/51 mg twice a day

New cards
19

What are the starting dose options for lisinopril

2.5-5 mg once a day

New cards
20

What are the starting dose options for valsartan

40 mg twice daily

New cards
21

What is the target dose for sacubitril/valsartan

97/103 mg twice daily

New cards
22

What is the target dose for lisinopril

20-40 mg daily

New cards
23

What is the target dose for valsartan

160 mg twice daily

New cards
24

How many days do you wait to assess tolerability, BP, electrolytes, and renal function in patients starting an MRA?

in 7 days

New cards
25

When do you increase the dose for MRAs

increase the dose stepwise at least every 2 weeks to target dosing and monitoring appropriately

New cards
26

Contraindications for MRAs in HFrEF

eGFR < 30 mL/min/1.73m2 or creatinine > 2.5 mg/dL in men and creatinine > 2 mg/dL in women

New cards
27

Special monitoring for MRAs in HFrEF

electrolytes and renal function 7 days after initiation/titration - after a stable dose check these monthly for 3 months and then every 3 months out to a year

New cards
28

Starting dose for spironolactone

12.5-25 mg once daily

New cards
29

Target dose for spironolactone

25-50 mg once daily

New cards
30

How do the doses of MRAs differ for heart failure compared to patients with HTN?

The doses are lower than what is generally used for HTN

New cards
31

Which SGLT inhibitors do you have to check that the patients eGFR is >= 25 g/mL/1.73m2?

dapagliflozin and sotagliflozin

New cards
32

when do you increase the dose of sotagliflozin

increase the dose stepwise to the target dosing in 2 weeks

New cards
33

Contraindications for SGLT inhibitors

Patients with type I diabetes

New cards
34

Starting dose for dapagliflozin

10 mg once daily

New cards
35

Starting dose for empagliflozin

10 mg daily

New cards
36

Target dose for dapagliflozin

10 mg daily <3

New cards
37

Target dose for empagliflozin

10 mg once a day

New cards
38

Can empagliflozin and dapagliflozin be titrated up from 10 mg?

Yes, if concomitant diabetes for glucose control

New cards
39

starting dose of sotagliflozin

200 mg daily

New cards
40

target dose of sotagliflozin

400 mg daily

New cards
41

What needs to be monitored when using beta-blockers in HFrEF

monitor HR and BP after initiation and during titration

New cards
42

When do you increase the dose of beta-blockers in HF

increase the dose every 2 weeks stepwise to target dosing

New cards
43

starting dose of bisoprolol

2.5 mg daily

New cards
44

target dose of bisoprolol

10 mg daily

New cards
45

starting dose of metoprolol succinate

12.5-25 mg once a day

New cards
46

target dose of metoprolol succinate

200mg daily

New cards
47

Starting dose of carvedilol

3.125-6.25 mg twice daily

New cards
48

target dose of carvedilol

25 mg twice daily

if > 85 kg give patient 50 mg twice daily

New cards
49

What to monitor after giving loop diuretics?

bp, electrolytes, and renal function after initiation and during titration!

New cards
50

When do you titrate the dose of loop diuretics?

titrate to relief of congestion which may be over days or weeks - increase as needed to maintain euvolemia and to

New cards
51

What is the usual start dose of furosemide?

~20-40 mg orally

New cards
52

Why are frequent clinic visits needed for loop diuretics

Need frequent clinic visits until patient is titrated to optimal effect, and may need to prescribe PO potassium in conjunction

New cards
53

If patients have increased distal sodium reabsorption from chronic loop diuretic use what med can be added on?

A thiazide

New cards
54

If a patient has poor delivery of the loop diuretic to the site of effect due to reduced GFR, HF, or gut edema, what can be done?

Increase the dose of loop diuretic

New cards
55

Furosemide 20 mg IV is equivalent to what dose orally?

40 mg

New cards
56

Furosemide 20 mg IV is equivalent to what dose of IV torsemide?

20 mg

New cards
57

Furosemide 20 mg IV is equivalent to what dose of IV bumetanide

1 mg

New cards
58

Furosemide 20 mg IV is equivalent to what dose of IV ethacrynic acid

50 mg

New cards
59

Furosemide 40 mg orally is equivalent to what dose of oral torsemide

20 mg

New cards
60

Furosemide 40 mg orally is equivalent to what dose of oral bumetanide

1 mg

New cards
61

Furosemide 40 mg orally is equivalent to what dose of oral ethacrynic acid

50 mg

New cards
62

Torsemide 20 mg IV is equivalent to what dose orally?

20 mg

New cards
63

Bumetanide 1 mg IV is equivalent to what dose orally?

1 mg

New cards
64

ethacrynic acid 50 mg IV is equivalent to what dose orally?

50 mg

New cards
65

What needs to be monitored when starting hydralazine/isosorbide dinitrate/combo pill

Bp after initiation and during titration

New cards
66

When do you need to increase the dose of hydralazine/isosorbide dinitrate/combo pill

increase the dose every 2 weeks stepwise until at target dosing

New cards
67

hydralazine target dose

75 mg TID

New cards
68

Isosorbide dinitrate target dose

40 mg TID

New cards
69

BiDil target dose

2 tablets TID

New cards
70

What needs to be confirmed before starting ivabradine

confirm beta-blocker is at maximally tolerated/targeted dose and that patient is in sinus rhythm

New cards
71

When to reassess HR in patients and increase stepwise to target dosing using ivabradine

in 2-4 weeks

New cards
72

How to titrate ivabradine in patients with a HR < 50 bpm or symptoms of bradycardia

Reduce dose by 2.5 mg twice daily or discontinue if already at 2.5 mg twice daily

New cards
73

How to titrate ivabradine in patients with a HR 50-60 bpm

maintain current dose and monitor HR

New cards
74

How to titrate ivabradine in patients with a HR > 60 bpm

increase by 2.5 mg twice daily until maximum dose of 7.5 mg twice daily

New cards
75

Pearl for ivabradine

Take with food!!!!

New cards
76

Starting dose of ivabradine

2.5 mg twice daily with food

New cards
77

target dose of ivabradine

7.5 mg twice daily with food!!

New cards
78

What needs to be confirmed before starting a patient on vericiguat

Confirm EF < 45% on maximally tolerated GDMT and has worsening symptoms (recent hospitalization or need for IV diuretics) along with a negative pregnancy test

New cards
79

What needs to be monitored in patients using vericiguat

BP and CBC (anemia) during initiation and titrate

New cards
80

Pearl for vericiguat

Take with food !!

New cards
81

starting dose of vericiguat

2.5 mg daily with food

New cards
82

target dose of vericiguat

10 mg daily with food

New cards
83

Other (rare) therapy options for patients with symptomatic HFrEF and possibly arrhythmias?

digoxin (2b recommendation)

New cards
84

What is an additional therapy that can be used for patients with HF NYHA II-IV?

polyunsaturated fatty acids (PUFA) (2b recommendation)

New cards
85

What is an additional therapy that can be used for patients with HF and hyperkalemia when taking RAASi

potassium binders (2b recommendation)

New cards
86

When may digoxin be added to a medication regimen?

If patient is already on other GDMT and patient is still symptomatic

New cards
87

What are the risks associated with digoxin

cardiac arrhythmias, GI symptoms (anorexia, N/V), neurological symptoms (visual disturbances, disorientation, confusion)

New cards
88

Target plasma concentration for digoxin used in HF

0.5-0.9 ng/mL

New cards
89

Can you develop digoxin toxicity if your plasma concentration is at target (0.5-0.9 ng/mL)?

Yes 😟

New cards
90

Why should you avoid Non-DHP CCBs in HFrEF?

Can worsen EF/CO

New cards
91

Why should you avoid class IC antiarrhythmic drugs and dronedarone in HFrEF?

Increased mortality

New cards
92

Why should you avoid thiazolidinediones in HFrEF?

worsens HF symptoms and hospitalizations

New cards
93

Why should you avoid DPP-4s (saxagliptin and alogliptin) in HFrEF?

increases HF hospitalizations

New cards
94

Why should you avoid NSAIDs in HFrEF?

Worsens HF symptoms (fluid overload)

New cards

Explore top notes

note Note
studied byStudied by 23 people
... ago
5.0(1)
note Note
studied byStudied by 33 people
... ago
5.0(1)
note Note
studied byStudied by 39 people
... ago
5.0(1)
note Note
studied byStudied by 19 people
... ago
5.0(1)
note Note
studied byStudied by 8 people
... ago
5.0(1)
note Note
studied byStudied by 29 people
... ago
5.0(1)
note Note
studied byStudied by 7 people
... ago
5.0(1)
note Note
studied byStudied by 34761 people
... ago
4.8(363)

Explore top flashcards

flashcards Flashcard (36)
studied byStudied by 2 people
... ago
5.0(1)
flashcards Flashcard (102)
studied byStudied by 69 people
... ago
5.0(2)
flashcards Flashcard (366)
studied byStudied by 6 people
... ago
5.0(1)
flashcards Flashcard (38)
studied byStudied by 8 people
... ago
5.0(2)
flashcards Flashcard (70)
studied byStudied by 1 person
... ago
5.0(1)
flashcards Flashcard (25)
studied byStudied by 14 people
... ago
5.0(1)
flashcards Flashcard (152)
studied byStudied by 32 people
... ago
5.0(2)
flashcards Flashcard (56)
studied byStudied by 4 people
... ago
5.0(1)
robot